Concepts (301)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 36 | 2024 | 306 | 14.170 |
Why?
|
| Asthma | 49 | 2025 | 1039 | 11.610 |
Why?
|
| Nebulizers and Vaporizers | 22 | 2025 | 62 | 6.490 |
Why?
|
| Patient Readmission | 14 | 2024 | 403 | 6.190 |
Why?
|
| Health Literacy | 13 | 2025 | 85 | 5.520 |
Why?
|
| Patient Education as Topic | 16 | 2020 | 381 | 4.220 |
Why?
|
| Metered Dose Inhalers | 13 | 2022 | 33 | 4.000 |
Why?
|
| Hospitalization | 21 | 2024 | 924 | 3.860 |
Why?
|
| Inpatients | 16 | 2024 | 341 | 3.550 |
Why?
|
| Anti-Asthmatic Agents | 12 | 2025 | 93 | 3.470 |
Why?
|
| Patient Care Bundles | 5 | 2023 | 20 | 2.510 |
Why?
|
| Administration, Inhalation | 21 | 2025 | 203 | 2.310 |
Why?
|
| Humans | 127 | 2025 | 93132 | 1.780 |
Why?
|
| Surveys and Questionnaires | 16 | 2025 | 2787 | 1.600 |
Why?
|
| School Health Services | 5 | 2019 | 16 | 1.590 |
Why?
|
| Telemedicine | 6 | 2024 | 223 | 1.550 |
Why?
|
| Inhalation Spacers | 2 | 2021 | 2 | 1.340 |
Why?
|
| Hospital Medicine | 3 | 2025 | 27 | 1.230 |
Why?
|
| Length of Stay | 4 | 2024 | 820 | 1.190 |
Why?
|
| Biomedical Research | 5 | 2025 | 432 | 1.170 |
Why?
|
| Child | 27 | 2025 | 7273 | 1.160 |
Why?
|
| Quality of Health Care | 5 | 2024 | 376 | 1.120 |
Why?
|
| Female | 60 | 2025 | 48542 | 1.090 |
Why?
|
| Male | 57 | 2025 | 44355 | 1.080 |
Why?
|
| Pain Management | 2 | 2025 | 180 | 0.980 |
Why?
|
| Patient Discharge | 4 | 2023 | 350 | 0.970 |
Why?
|
| Self-Management | 3 | 2024 | 44 | 0.970 |
Why?
|
| United States | 23 | 2025 | 7581 | 0.960 |
Why?
|
| Parents | 5 | 2020 | 292 | 0.950 |
Why?
|
| Equipment Failure | 2 | 2020 | 119 | 0.930 |
Why?
|
| Cross-Sectional Studies | 12 | 2025 | 1849 | 0.930 |
Why?
|
| Chicago | 13 | 2025 | 1452 | 0.930 |
Why?
|
| Vision, Low | 2 | 2015 | 15 | 0.910 |
Why?
|
| Child, Hospitalized | 2 | 2023 | 38 | 0.900 |
Why?
|
| Virtual Reality | 1 | 2025 | 37 | 0.870 |
Why?
|
| Adult | 27 | 2025 | 27849 | 0.850 |
Why?
|
| Vision Disorders | 2 | 2016 | 71 | 0.840 |
Why?
|
| Middle Aged | 30 | 2025 | 27535 | 0.840 |
Why?
|
| Research Personnel | 2 | 2025 | 78 | 0.840 |
Why?
|
| Minority Groups | 5 | 2019 | 149 | 0.830 |
Why?
|
| Patient Participation | 3 | 2024 | 229 | 0.820 |
Why?
|
| Attitude of Health Personnel | 3 | 2025 | 648 | 0.810 |
Why?
|
| Research | 1 | 2025 | 250 | 0.810 |
Why?
|
| Health Status Disparities | 2 | 2017 | 218 | 0.810 |
Why?
|
| Hospitals | 4 | 2023 | 329 | 0.800 |
Why?
|
| Quality of Life | 9 | 2025 | 1776 | 0.780 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2021 | 135 | 0.780 |
Why?
|
| Leadership | 1 | 2025 | 149 | 0.780 |
Why?
|
| Anemia, Sickle Cell | 1 | 2025 | 145 | 0.770 |
Why?
|
| Hospitalists | 1 | 2025 | 135 | 0.770 |
Why?
|
| Community Health Workers | 2 | 2022 | 36 | 0.760 |
Why?
|
| Patients | 3 | 2020 | 103 | 0.760 |
Why?
|
| Educational Measurement | 2 | 2016 | 236 | 0.750 |
Why?
|
| Nonprescription Drugs | 1 | 2022 | 17 | 0.730 |
Why?
|
| Education, Medical, Undergraduate | 4 | 2025 | 180 | 0.710 |
Why?
|
| Quality Improvement | 4 | 2020 | 482 | 0.700 |
Why?
|
| Students, Medical | 5 | 2025 | 433 | 0.690 |
Why?
|
| Mass Screening | 3 | 2017 | 706 | 0.680 |
Why?
|
| Physician-Patient Relations | 6 | 2016 | 561 | 0.680 |
Why?
|
| Women | 1 | 2021 | 26 | 0.660 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2025 | 289 | 0.650 |
Why?
|
| Awards and Prizes | 1 | 2021 | 37 | 0.650 |
Why?
|
| Medical Overuse | 1 | 2020 | 30 | 0.650 |
Why?
|
| Adolescent | 12 | 2025 | 9550 | 0.640 |
Why?
|
| Drug Misuse | 1 | 2020 | 2 | 0.640 |
Why?
|
| Research Support as Topic | 1 | 2021 | 89 | 0.640 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2024 | 284 | 0.630 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 1229 | 0.630 |
Why?
|
| Emergency Service, Hospital | 6 | 2023 | 576 | 0.630 |
Why?
|
| Deductibles and Coinsurance | 1 | 2020 | 8 | 0.620 |
Why?
|
| Practice Guidelines as Topic | 5 | 2019 | 1054 | 0.610 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 557 | 0.600 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 218 | 0.600 |
Why?
|
| Risk Factors | 8 | 2024 | 5900 | 0.600 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 1910 | 0.590 |
Why?
|
| Disease Management | 3 | 2020 | 357 | 0.580 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 173 | 0.570 |
Why?
|
| Natural Language Processing | 1 | 2019 | 42 | 0.560 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2025 | 69 | 0.550 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 752 | 0.530 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 762 | 0.530 |
Why?
|
| Schools | 2 | 2018 | 84 | 0.530 |
Why?
|
| Aged | 17 | 2025 | 20395 | 0.520 |
Why?
|
| Attitude to Health | 1 | 2018 | 214 | 0.510 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.500 |
Why?
|
| Prospective Studies | 11 | 2024 | 4546 | 0.500 |
Why?
|
| Social Media | 1 | 2019 | 111 | 0.500 |
Why?
|
| Respiratory System Agents | 1 | 2016 | 7 | 0.490 |
Why?
|
| Accidental Falls | 1 | 2016 | 47 | 0.480 |
Why?
|
| Health Policy | 5 | 2018 | 205 | 0.470 |
Why?
|
| Delirium | 2 | 2016 | 79 | 0.470 |
Why?
|
| Point-of-Care Testing | 1 | 2015 | 28 | 0.460 |
Why?
|
| Data Collection | 3 | 2013 | 370 | 0.460 |
Why?
|
| Psychometrics | 2 | 2023 | 336 | 0.460 |
Why?
|
| Spirometry | 4 | 2023 | 77 | 0.450 |
Why?
|
| Disease Progression | 1 | 2020 | 1529 | 0.450 |
Why?
|
| Eyeglasses | 1 | 2015 | 8 | 0.450 |
Why?
|
| Patient Care Team | 2 | 2018 | 297 | 0.450 |
Why?
|
| Retrospective Studies | 8 | 2024 | 10128 | 0.440 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 338 | 0.440 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.440 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 2 | 2025 | 27 | 0.440 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 496 | 0.430 |
Why?
|
| Medicare | 3 | 2024 | 451 | 0.430 |
Why?
|
| Comorbidity | 3 | 2024 | 1003 | 0.430 |
Why?
|
| Pediatrics | 1 | 2019 | 378 | 0.430 |
Why?
|
| Patient Advocacy | 1 | 2015 | 63 | 0.420 |
Why?
|
| HIV Infections | 1 | 2023 | 952 | 0.410 |
Why?
|
| Trust | 2 | 2016 | 97 | 0.410 |
Why?
|
| Guideline Adherence | 4 | 2024 | 237 | 0.390 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 65 | 0.390 |
Why?
|
| Logistic Models | 3 | 2022 | 1240 | 0.390 |
Why?
|
| Heart Failure | 1 | 2023 | 1376 | 0.390 |
Why?
|
| Internship and Residency | 4 | 2012 | 1074 | 0.380 |
Why?
|
| Medical Staff, Hospital | 1 | 2013 | 102 | 0.380 |
Why?
|
| Formoterol Fumarate | 2 | 2025 | 10 | 0.360 |
Why?
|
| Physicians | 3 | 2020 | 668 | 0.360 |
Why?
|
| Family | 1 | 2013 | 319 | 0.350 |
Why?
|
| Urban Population | 4 | 2018 | 234 | 0.350 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 483 | 0.340 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2025 | 916 | 0.340 |
Why?
|
| Schools, Medical | 4 | 2024 | 131 | 0.330 |
Why?
|
| Cognition | 1 | 2015 | 625 | 0.330 |
Why?
|
| Child, Preschool | 6 | 2023 | 3781 | 0.330 |
Why?
|
| Aging | 1 | 2015 | 725 | 0.330 |
Why?
|
| Minority Health | 1 | 2010 | 10 | 0.320 |
Why?
|
| Societies, Medical | 3 | 2024 | 618 | 0.320 |
Why?
|
| Prevalence | 4 | 2024 | 1318 | 0.310 |
Why?
|
| Chronic Disease | 3 | 2023 | 941 | 0.310 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2024 | 53 | 0.310 |
Why?
|
| Cost Savings | 2 | 2022 | 67 | 0.310 |
Why?
|
| Feasibility Studies | 4 | 2020 | 753 | 0.300 |
Why?
|
| Self Administration | 3 | 2018 | 76 | 0.300 |
Why?
|
| Self Care | 4 | 2016 | 167 | 0.300 |
Why?
|
| Poverty | 3 | 2019 | 192 | 0.290 |
Why?
|
| Teaching | 1 | 2010 | 138 | 0.290 |
Why?
|
| Time Factors | 4 | 2024 | 5380 | 0.280 |
Why?
|
| Patient Outcome Assessment | 3 | 2017 | 85 | 0.280 |
Why?
|
| Educational Status | 2 | 2023 | 195 | 0.270 |
Why?
|
| Young Adult | 5 | 2025 | 6922 | 0.270 |
Why?
|
| Qualitative Research | 3 | 2025 | 346 | 0.270 |
Why?
|
| Sex Factors | 2 | 2024 | 1102 | 0.270 |
Why?
|
| Equipment Design | 2 | 2021 | 411 | 0.260 |
Why?
|
| Comparative Effectiveness Research | 2 | 2020 | 57 | 0.260 |
Why?
|
| Students | 2 | 2018 | 177 | 0.250 |
Why?
|
| Self Concept | 2 | 2019 | 135 | 0.250 |
Why?
|
| Internet | 2 | 2020 | 345 | 0.240 |
Why?
|
| Socioeconomic Factors | 3 | 2018 | 627 | 0.240 |
Why?
|
| Registries | 2 | 2024 | 995 | 0.240 |
Why?
|
| Curriculum | 2 | 2024 | 590 | 0.230 |
Why?
|
| Communication Barriers | 2 | 2015 | 31 | 0.230 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 480 | 0.230 |
Why?
|
| Medical History Taking | 1 | 2025 | 80 | 0.220 |
Why?
|
| Muscarinic Antagonists | 1 | 2025 | 59 | 0.220 |
Why?
|
| Program Evaluation | 2 | 2020 | 312 | 0.220 |
Why?
|
| Cost Sharing | 1 | 2024 | 20 | 0.210 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2025 | 122 | 0.210 |
Why?
|
| Electronic Health Records | 3 | 2017 | 373 | 0.210 |
Why?
|
| Delphi Technique | 1 | 2024 | 135 | 0.200 |
Why?
|
| Physicians, Primary Care | 1 | 2025 | 106 | 0.200 |
Why?
|
| Checklist | 2 | 2016 | 73 | 0.200 |
Why?
|
| Health Promotion | 2 | 2024 | 170 | 0.200 |
Why?
|
| Control Groups | 1 | 2023 | 16 | 0.200 |
Why?
|
| Diagnosis-Related Groups | 1 | 2023 | 21 | 0.200 |
Why?
|
| Dry Powder Inhalers | 2 | 2020 | 3 | 0.200 |
Why?
|
| Primary Health Care | 3 | 2025 | 369 | 0.190 |
Why?
|
| Sex Distribution | 2 | 2021 | 174 | 0.190 |
Why?
|
| Chronic Pain | 1 | 2025 | 187 | 0.190 |
Why?
|
| Health Equity | 1 | 2024 | 101 | 0.180 |
Why?
|
| Health Expenditures | 2 | 2024 | 98 | 0.180 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 154 | 0.180 |
Why?
|
| Polysomnography | 1 | 2022 | 152 | 0.180 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 888 | 0.170 |
Why?
|
| Aftercare | 1 | 2022 | 89 | 0.170 |
Why?
|
| Syndrome | 1 | 2022 | 432 | 0.170 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 30 | 0.170 |
Why?
|
| Exercise | 1 | 2024 | 353 | 0.170 |
Why?
|
| Cross Infection | 2 | 2013 | 149 | 0.170 |
Why?
|
| Feedback | 1 | 2021 | 129 | 0.170 |
Why?
|
| Exercise Therapy | 1 | 2021 | 94 | 0.170 |
Why?
|
| Insurance, Health | 2 | 2020 | 175 | 0.170 |
Why?
|
| Physician's Role | 2 | 2013 | 175 | 0.160 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 3814 | 0.160 |
Why?
|
| Focus Groups | 2 | 2018 | 184 | 0.160 |
Why?
|
| Needs Assessment | 2 | 2018 | 167 | 0.160 |
Why?
|
| School Nursing | 1 | 2019 | 3 | 0.150 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 136 | 0.150 |
Why?
|
| Mentors | 2 | 2023 | 95 | 0.150 |
Why?
|
| Machine Learning | 1 | 2022 | 346 | 0.140 |
Why?
|
| Prescription Fees | 1 | 2018 | 9 | 0.140 |
Why?
|
| Desensitization, Immunologic | 1 | 2019 | 46 | 0.140 |
Why?
|
| Cause of Death | 1 | 2020 | 271 | 0.140 |
Why?
|
| Patient Rights | 1 | 2018 | 15 | 0.140 |
Why?
|
| Research Design | 2 | 2024 | 620 | 0.140 |
Why?
|
| Pandemics | 2 | 2025 | 873 | 0.140 |
Why?
|
| Nurses | 1 | 2018 | 41 | 0.140 |
Why?
|
| Respiration Disorders | 1 | 2018 | 42 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 984 | 0.140 |
Why?
|
| Congresses as Topic | 1 | 2019 | 121 | 0.140 |
Why?
|
| Counseling | 2 | 2010 | 164 | 0.140 |
Why?
|
| Allergens | 1 | 2019 | 188 | 0.140 |
Why?
|
| Awareness | 1 | 2018 | 89 | 0.140 |
Why?
|
| Risk Assessment | 4 | 2021 | 2434 | 0.130 |
Why?
|
| Health Education | 1 | 2018 | 105 | 0.130 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2017 | 12 | 0.130 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2705 | 0.130 |
Why?
|
| Videoconferencing | 1 | 2017 | 18 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 7039 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 290 | 0.130 |
Why?
|
| Lung | 2 | 2022 | 1359 | 0.130 |
Why?
|
| Inhalation | 1 | 2017 | 34 | 0.130 |
Why?
|
| Language | 2 | 2015 | 160 | 0.130 |
Why?
|
| Community Participation | 1 | 2017 | 39 | 0.130 |
Why?
|
| Videotape Recording | 1 | 2017 | 49 | 0.120 |
Why?
|
| Microcomputers | 1 | 2016 | 24 | 0.120 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 221 | 0.120 |
Why?
|
| Internal Medicine | 2 | 2010 | 327 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2020 | 1518 | 0.120 |
Why?
|
| Sleep | 2 | 2023 | 448 | 0.120 |
Why?
|
| Mental Status Schedule | 1 | 2016 | 26 | 0.120 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 40 | 0.120 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 87 | 0.120 |
Why?
|
| Bronchodilator Agents | 3 | 2024 | 70 | 0.120 |
Why?
|
| Face | 1 | 2016 | 108 | 0.120 |
Why?
|
| Medicaid | 1 | 2019 | 245 | 0.120 |
Why?
|
| Multilingualism | 1 | 2015 | 10 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1519 | 0.120 |
Why?
|
| Advisory Committees | 1 | 2016 | 90 | 0.120 |
Why?
|
| Motivation | 1 | 2018 | 310 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2016 | 107 | 0.110 |
Why?
|
| Problem Solving | 1 | 2015 | 55 | 0.110 |
Why?
|
| Acetates | 1 | 2015 | 57 | 0.110 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 39 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2024 | 3044 | 0.110 |
Why?
|
| Translating | 1 | 2015 | 17 | 0.110 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 64 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1160 | 0.110 |
Why?
|
| Androstadienes | 1 | 2015 | 71 | 0.110 |
Why?
|
| Vision Tests | 1 | 2015 | 20 | 0.110 |
Why?
|
| Quinolines | 1 | 2015 | 85 | 0.110 |
Why?
|
| Linear Models | 1 | 2016 | 413 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 451 | 0.110 |
Why?
|
| Acute Disease | 1 | 2017 | 838 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2015 | 72 | 0.110 |
Why?
|
| Mobile Applications | 1 | 2016 | 78 | 0.110 |
Why?
|
| Patient Selection | 1 | 2017 | 688 | 0.100 |
Why?
|
| Software | 1 | 2017 | 669 | 0.100 |
Why?
|
| Memory | 1 | 2015 | 225 | 0.100 |
Why?
|
| Drug Therapy, Combination | 2 | 2025 | 753 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 353 | 0.090 |
Why?
|
| Communication | 1 | 2016 | 433 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 1098 | 0.090 |
Why?
|
| Interviews as Topic | 2 | 2025 | 359 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2025 | 9070 | 0.080 |
Why?
|
| Cooperative Behavior | 2 | 2023 | 191 | 0.070 |
Why?
|
| Documentation | 2 | 2020 | 97 | 0.060 |
Why?
|
| Muscle Stretching Exercises | 1 | 2024 | 1 | 0.050 |
Why?
|
| Caregivers | 2 | 2017 | 171 | 0.050 |
Why?
|
| Muscle Strength | 1 | 2024 | 38 | 0.050 |
Why?
|
| Medication Therapy Management | 1 | 2024 | 18 | 0.050 |
Why?
|
| Medicare Part C | 1 | 2024 | 7 | 0.050 |
Why?
|
| Postural Balance | 1 | 2024 | 53 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2024 | 58 | 0.050 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 37 | 0.050 |
Why?
|
| Actigraphy | 1 | 2024 | 61 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 913 | 0.050 |
Why?
|
| Walking | 1 | 2024 | 104 | 0.050 |
Why?
|
| Staff Development | 1 | 2023 | 26 | 0.050 |
Why?
|
| Quality Indicators, Health Care | 2 | 2016 | 151 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2023 | 187 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 194 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 515 | 0.040 |
Why?
|
| Sodium | 1 | 2021 | 328 | 0.040 |
Why?
|
| Efficiency | 1 | 2020 | 39 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 378 | 0.040 |
Why?
|
| Glucose | 1 | 2021 | 686 | 0.040 |
Why?
|
| Child Welfare | 1 | 2018 | 43 | 0.030 |
Why?
|
| Health Information Exchange | 1 | 2017 | 12 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 279 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 51 | 0.030 |
Why?
|
| Confidentiality | 1 | 2016 | 75 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 570 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2015 | 16 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 147 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 129 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2015 | 62 | 0.030 |
Why?
|
| Mental Recall | 1 | 2016 | 172 | 0.030 |
Why?
|
| Illinois | 1 | 2015 | 515 | 0.020 |
Why?
|
| Pneumococcal Vaccines | 1 | 2013 | 32 | 0.020 |
Why?
|
| Catheter-Related Infections | 1 | 2013 | 24 | 0.020 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2012 | 19 | 0.020 |
Why?
|
| Pressure Ulcer | 1 | 2013 | 44 | 0.020 |
Why?
|
| Sick Leave | 1 | 2012 | 15 | 0.020 |
Why?
|
| Workplace | 1 | 2012 | 32 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2015 | 373 | 0.020 |
Why?
|
| Attention | 1 | 2016 | 410 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2015 | 450 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 2545 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 257 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 1697 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 337 | 0.020 |
Why?
|